Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Jane Tomimori, Walmar Roncalli Pereira de Oliveira, Carla Ferrándiz-Pulido, Marilia Marufuji Ogawa, editors.
    Summary: The number of solid organ transplant recipients is increasing worldwide every year, which has meant a significant improvement of recipients survival and quality of life. To prevent graft rejection, patients require long-term immunosuppression, which is responsible for their increased risk of neoplastic and infectious diseases. This practical and concise atlas presents the most important dermatoses in solid organ transplant recipients. Providing a guide to diagnosis and appropriate therapy, it helps dermatologists, general practitioners and physicians manage the dermatoses found in organ transplant recipients. The first three chapters discuss immunosuppressive regimens and the prevalence of dermatoses, while the other chapters approach the main diseases didactically, providing a large number of illustrations.

    Contents:
    1. Immunosuppression and solid organ transplantation
    2. Overview of dermatological diseases after transplantation
    3. Cutaneous side effects of immunosuppressive drugs other than neoplasms
    4. Viral Diseases
    5. Bacterial diseases
    6. Mycobacterial diseases
    7. Superficial fungal diseases
    8. Deep Fungal diseases
    9. Parasitic diseases
    10. Sexually transmitted infections
    11. Precancerous manifestations
    12. Squamous cell carcinoma
    13. Basal cell carcinoma
    14. Melanoma
    15. Kaposi sarcoma
    16. Lymphoproliferative diseases
    17. Other rare cancers.
    Digital Access Springer 2022
  • Article
    Piehler JM, Crichlow RW.
    Surg Gynecol Obstet. 1978 Dec;147(6):929-42.
    Data from 6,222 patients with primary carcinoma of the gallbladder reported upon in the past 15 years have been analyzed. The disease occurs predominately in elderly females who often present with extremes of clinical symptoms, suggesting, on one hand, benign calculous disease or, on the other, advanced incurable malignant disease. Laboratory and x-ray data tend to confirm the clinical diagnosis of incurable disease, but do not aid in determining those patients with early, potentially curable lesions. The biologic nature of the tumor makes most carcinomas unsuspected findings at the time of operation and limits those patients presenting with resectable disease to about 25 per cent. The over-all five year survival of patients with carcinoma of the gallbladder is only 4.1 per cent. Furthermore, virtually the only survivors are those with lesions resected early that were not apparent to the operating surgeon and of the papillary cell type without significant invasion of the wall of the gallbladder. If the tumor is recognized and believed to be resected, survival is only 2.9 per cent, with failures caused by locally recurrent tumor. Despite the obvious failure of management of carcinoma of the gallbladder, therapeutic advantage has not been taken of the tumor's propensity to remain locally invasive by extending the scope of the traditional cholecystectomy to include en bloc hepatic wedge resection and regional lymphadenectomy in treating patients with recognized malignant tumors. Reoperation for delayed hepatic resection and lymph node dissection should be considered in selected patients with carcinoma unsuspected at operation but noted in the resected specimen. Selected application of this approach might offer the chance of cure to a small, but definite, group of patients who are currently being undertreated.
    Digital Access Access Options